Prospective evaluation of mesopic visual acuity in cataract patients implanted with a novel full range of vision intraocular lens
CLOSE
MENU

Prospective evaluation of mesopic visual acuity in cataract patients implanted with a novel full range of vision intraocular lens


Content provided by Bausch + Lomb Global Medical and Scientific Affairs.

Prospective evaluation of mesopic visual acuity in cataract patients implanted with a novel full range of vision intraocular lens


Content provided by Bausch + Lomb Global Medical and Scientific Affairs.

Summary

PURPOSE: To evaluate the mesopic monocular and binocular visual acuity outcomes following implantation of either a novel Full Range of Vision enVista IOL or monofocal enVista IOL in US subjects undergoing cataract surgery.

METHODS: This prospective, multicenter, randomized, controlled study included cataract subjects who underwent bilateral implantation of either enVista Envy full range of vision (FRoV) IOL (study group, N=284) or enVista monofocal IOL (control group, N = 142). Outcome measures included assessment of the monocular and binocular distance-corrected visual acuity at intermediate (DCIVA, 66 cm) and near (DCNVA, 40 cm) under mesopic conditions at postoperative 120-180 days.

RESULTS: Postoperatively, the FRoV group showed significantly better mean mesopic DCIVA (monocular 0.29 ± 0.14 vs 0.46 ± 0.16 logMAR and binocular 0.21 ± 0.12 vs 0.39 ± 0.13 logMAR) compared to the monofocal group (both p<0.0001). Similarly, the mesopic DCNVA was also statistically significantly better in the FRoV group (monocular 0.35 ± 0.15 logMAR vs 0.66 ± 0.18 logMAR and binocular 0.26 ± 0.13 logMAR vs 0.59 ± 0.15 logMAR) compared to the monofocal group (both p<0.0001).

CONCLUSION: The Envy FRoV IOL showed good binocular mesopic DCIVA (20/32) and DCNVA (20/37), suggesting that the FRoV IOL had good efficacy even under mesopic conditions. While the Envy FRoV group demonstrated a mean binocular DCIVA of more than 2 lines better, the mean DCNVA was approximately 4 lines better than the monofocal group.

For More Information:

Get Support

Contact Us

Contact a
Representative

Find My Local Rep link-out icon

Submit a
Medical Inquiry

Complete the Form